N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141207 |
| CAS No | NA |
| Mol.F. | C21H21N9O6 : 2(Na) |
| Mol.Wt. | 495.5 : 2(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141208 |
| CAS No | NA |
| Mol.F. | C17H23N3O6 |
| Mol.Wt. | 365.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141209 |
| CAS No | NA |
| Mol.F. | C17H22N4O7 |
| Mol.Wt. | 394.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141210 |
| CAS No | NA |
| Mol.F. | C13H14N4O7 |
| Mol.Wt. | 338.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141211 |
| CAS No | NA |
| Mol.F. | C20H21N9O6 |
| Mol.Wt. | 483.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141212 |
| CAS No | NA |
| Mol.F. | C20H21N9O6 |
| Mol.Wt. | 483.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141213 |
| CAS No | NA |
| Mol.F. | C11H16N2O |
| Mol.Wt. | 192.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141214 |
| CAS No | 871884-77-4 |
| Mol.F. | C18H22N2O |
| Mol.Wt. | 282.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141215 |
| CAS No | NA |
| Mol.F. | C6H3ClN4O |
| Mol.Wt. | 182.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141216 |
| CAS No | NA |
| Mol.F. | C3H2BrN3O |
| Mol.Wt. | 176.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141217 |
| CAS No | NA |
| Mol.F. | C14H12N8O |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141218 |
| CAS No | NA |
| Mol.F. | C17H18N8O3S |
| Mol.Wt. | 414.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141219 |
| CAS No | NA |
| Mol.F. | C6H4N4O2 |
| Mol.Wt. | 164.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141220 |
| CAS No | NA |
| Mol.F. | C10H15BN2O3 |
| Mol.Wt. | 222.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141221 |
| CAS No | NA |
| Mol.F. | C15H20N6O2Si |
| Mol.Wt. | 344.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141222 |
| CAS No | NA |
| Mol.F. | C17H19N7O2 |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |